Vicapsys Life Sciences (VICP) Price & Analysis

2 Followers

VICP Stock Chart & Stats

$1.46

-$1.51(-100.00%)

At close: Dec 10 4:00 PM EST

$1.46

-$1.51(-100.00%)

Day’s Range― - ―

52-Week Range$0.15 - $1.77

Previous CloseN/A

Volume2.41K

Average Volume (3M)0.00

Market Cap

$47.26M

Enterprise Value$47.84M

Total Cash (Recent Filing)$132.54K

Total Debt (Recent Filing)$624.35K

Price to Earnings (P/E)―

Beta1103394.00

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding32,371,300

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio2.38

Price to Book (P/B)-14.82

Price to Sales (P/S)0.00

P/FCF Ratio-2.47K

Enterprise Value/Market Cap1.01

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/Ebitda-496.63

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

VICP FAQ

What was Vicapsys Life Sciences Inc’s price range in the past 12 months?

Vicapsys Life Sciences Inc lowest stock price was $0.15 and its highest was $1.77 in the past 12 months.

What is Vicapsys Life Sciences Inc’s market cap?

Vicapsys Life Sciences Inc’s market cap is $47.26M.

When is Vicapsys Life Sciences Inc’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Vicapsys Life Sciences Inc’s earnings last quarter?

Currently, no data Available

Is Vicapsys Life Sciences Inc overvalued?

According to Wall Street analysts Vicapsys Life Sciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Vicapsys Life Sciences Inc pay dividends?

Vicapsys Life Sciences Inc does not currently pay dividends.

What is Vicapsys Life Sciences Inc’s EPS estimate?

Vicapsys Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Vicapsys Life Sciences Inc have?

Vicapsys Life Sciences Inc has 32,371,300 shares outstanding.

What happened to Vicapsys Life Sciences Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Vicapsys Life Sciences Inc?

Currently, no hedge funds are holding shares in VICP

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Vicapsys Life Sciences Inc

Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive VICAPSYN product to market, guiding it through development and commercialization. This product's intended application is within the field of transplantation, specifically for various transplant therapies and associated stem-cell uses. Additionally, the company is advancing the development of VYBRIN, a compound based on CXCL12. VYBRIN is being investigated for multiple purposes: preventing the formation of post-surgical adhesions following abdominal operations, coating implantable medical devices and other implants to inhibit fibrosis, and promoting wound healing, with a particular emphasis on diabetic ulcers. The firm, originally incorporated in 1997, transitioned its name from Phage Therapeutics International, Inc. to Vicapsys Life Sciences, Inc. in September 2017. Its operations are headquartered in Suwanee, Georgia.